438 related articles for article (PubMed ID: 25340789)
41. Suppression of Kaposi's Sarcoma-Associated Herpesvirus Infection and Replication by 5'-AMP-Activated Protein Kinase.
Cheng F; He M; Jung JU; Lu C; Gao SJ
J Virol; 2016 Jul; 90(14):6515-6525. PubMed ID: 27147746
[TBL] [Abstract][Full Text] [Related]
42. Deregulation of HDAC5 by Viral Interferon Regulatory Factor 3 Plays an Essential Role in Kaposi's Sarcoma-Associated Herpesvirus-Induced Lymphangiogenesis.
Lee HR; Li F; Choi UY; Yu HR; Aldrovandi GM; Feng P; Gao SJ; Hong YK; Jung JU
mBio; 2018 Jan; 9(1):. PubMed ID: 29339432
[TBL] [Abstract][Full Text] [Related]
43. Kaposi's sarcoma herpesvirus-induced endothelial cell reprogramming supports viral persistence and contributes to Kaposi's sarcoma tumorigenesis.
Gramolelli S; Ojala PM
Curr Opin Virol; 2017 Oct; 26():156-162. PubMed ID: 29031103
[TBL] [Abstract][Full Text] [Related]
44. Reactive oxygen species hydrogen peroxide mediates Kaposi's sarcoma-associated herpesvirus reactivation from latency.
Ye F; Zhou F; Bedolla RG; Jones T; Lei X; Kang T; Guadalupe M; Gao SJ
PLoS Pathog; 2011 May; 7(5):e1002054. PubMed ID: 21625536
[TBL] [Abstract][Full Text] [Related]
45. Glutamate secretion and metabotropic glutamate receptor 1 expression during Kaposi's sarcoma-associated herpesvirus infection promotes cell proliferation.
Valiya Veettil M; Dutta D; Bottero V; Bandyopadhyay C; Gjyshi O; Sharma-Walia N; Dutta S; Chandran B
PLoS Pathog; 2014 Oct; 10(10):e1004389. PubMed ID: 25299066
[TBL] [Abstract][Full Text] [Related]
46. Transformation of primary human endothelial cells by Kaposi's sarcoma-associated herpesvirus.
Flore O; Rafii S; Ely S; O'Leary JJ; Hyjek EM; Cesarman E
Nature; 1998 Aug; 394(6693):588-92. PubMed ID: 9707121
[TBL] [Abstract][Full Text] [Related]
47. 3D culture conditions support Kaposi's sarcoma herpesvirus (KSHV) maintenance and viral spread in endothelial cells.
Dubich T; Dittrich A; Bousset K; Geffers R; Büsche G; Köster M; Hauser H; Schulz TF; Wirth D
J Mol Med (Berl); 2021 Mar; 99(3):425-438. PubMed ID: 33484281
[TBL] [Abstract][Full Text] [Related]
48. Kaposi's sarcoma-associated herpesvirus (KSHV)/human herpesvirus 8 (HHV-8) as a tumour virus.
Cathomas G
Herpes; 2003 Dec; 10(3):72-7. PubMed ID: 14759339
[TBL] [Abstract][Full Text] [Related]
49. Differential viral protein expression in Kaposi's sarcoma-associated herpesvirus-infected diseases: Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease.
Parravicini C; Chandran B; Corbellino M; Berti E; Paulli M; Moore PS; Chang Y
Am J Pathol; 2000 Mar; 156(3):743-9. PubMed ID: 10702388
[TBL] [Abstract][Full Text] [Related]
50. The Kaposi's sarcoma-associated herpesvirus (KSHV)-induced 5-lipoxygenase-leukotriene B4 cascade plays key roles in KSHV latency, monocyte recruitment, and lipogenesis.
Sharma-Walia N; Chandran K; Patel K; Veettil MV; Marginean A
J Virol; 2014 Feb; 88(4):2131-56. PubMed ID: 24335295
[TBL] [Abstract][Full Text] [Related]
51. Characterization of de novo lytic infection of dermal lymphatic microvascular endothelial cells by Kaposi's sarcoma-associated herpesvirus.
Golas G; Alonso JD; Toth Z
Virology; 2019 Oct; 536():27-31. PubMed ID: 31394409
[TBL] [Abstract][Full Text] [Related]
52. Kaposi's sarcoma-associated herpesvirus latency in endothelial and B cells activates gamma interferon-inducible protein 16-mediated inflammasomes.
Singh VV; Kerur N; Bottero V; Dutta S; Chakraborty S; Ansari MA; Paudel N; Chikoti L; Chandran B
J Virol; 2013 Apr; 87(8):4417-31. PubMed ID: 23388709
[TBL] [Abstract][Full Text] [Related]
53. KSHV hijacks FoxO1 to promote cell proliferation and cellular transformation by antagonizing oxidative stress.
Li T; Gao SJ
J Med Virol; 2023 Mar; 95(3):e28676. PubMed ID: 36929740
[TBL] [Abstract][Full Text] [Related]
54. Kaposi's Sarcoma-Associated Herpesvirus (KSHV) Induces the Oncogenic miR-17-92 Cluster and Down-Regulates TGF-β Signaling.
Choi HS; Jain V; Krueger B; Marshall V; Kim CH; Shisler JL; Whitby D; Renne R
PLoS Pathog; 2015; 11(11):e1005255. PubMed ID: 26545119
[TBL] [Abstract][Full Text] [Related]
55. Latent KSHV infection of endothelial cells induces integrin beta3 to activate angiogenic phenotypes.
DiMaio TA; Gutierrez KD; Lagunoff M
PLoS Pathog; 2011 Dec; 7(12):e1002424. PubMed ID: 22174684
[TBL] [Abstract][Full Text] [Related]
56. An endothelial cell line infected by Kaposi's sarcoma-associated herpes virus (KSHV) allows the investigation of Kaposi's sarcoma and the validation of novel viral inhibitors in vitro and in vivo.
Dubich T; Lieske A; Santag S; Beauclair G; Rückert J; Herrmann J; Gorges J; Büsche G; Kazmaier U; Hauser H; Stadler M; Schulz TF; Wirth D
J Mol Med (Berl); 2019 Mar; 97(3):311-324. PubMed ID: 30610257
[TBL] [Abstract][Full Text] [Related]
57. Kaposi's sarcoma-associated herpesvirus-encoded interleukin-6 and G-protein-coupled receptor regulate angiopoietin-2 expression in lymphatic endothelial cells.
Vart RJ; Nikitenko LL; Lagos D; Trotter MW; Cannon M; Bourboulia D; Gratrix F; Takeuchi Y; Boshoff C
Cancer Res; 2007 May; 67(9):4042-51. PubMed ID: 17483315
[TBL] [Abstract][Full Text] [Related]
58. STAT3 Regulates Lytic Activation of Kaposi's Sarcoma-Associated Herpesvirus.
King CA; Li X; Barbachano-Guerrero A; Bhaduri-McIntosh S
J Virol; 2015 Nov; 89(22):11347-55. PubMed ID: 26339061
[TBL] [Abstract][Full Text] [Related]
59. Intracellular-activated Notch1 can reactivate Kaposi's sarcoma-associated herpesvirus from latency.
Lan K; Murakami M; Choudhuri T; Kuppers DA; Robertson ES
Virology; 2006 Aug; 351(2):393-403. PubMed ID: 16701788
[TBL] [Abstract][Full Text] [Related]
60. Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 infection in reactive lymphoid tissues: a model for KSHV/HHV-8-related lymphomas?
Lazzi S; Bellan C; Amato T; Palummo N; Cardone C; D'Amuri A; De Luca F; Beyanga M; Facchetti F; Tosi P; Leoncini L
Hum Pathol; 2006 Jan; 37(1):23-31. PubMed ID: 16360412
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
